Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Elite Execution Gaming PCs for Gamers - 2Merz visit highlights new strategic, and strained, Germany-Israel bond
- 3Flourishing in Retirement: Individual Accounts of Post-Vocation Satisfaction
- 4Israeli naval intelligence reduces Iranian threat to Strait of Hormuz
- 5Joshua Made Last-Second Seat Change That Saved His Life
- Nature's Treats: 10 Organic products That Lift Prosperity
- Several killed in Ukraine and Russia after cross-border attacks
- 4 Excellent Remote Headphones of 2024
- Commonsense Ways to work on Your Funds with a Restricted Pay
- Hostile to Maturing Skincare Items to Rejuvenate Your Skin
- Brazil passes anti-gang law allowing seized crypto to fund security forces
- Allow Innovative Progressions To have a Tremendous Effect
- Italian authorities detain civilian rescue ship, German NGO says
- Bahrain cracks down on dissent as war grinds on
